GlassScriptPhysician profile
Chelsey Roberts
NPI 1174996664
$2,568.13
in general payments reported to CMS, 2019-2025
29 companies · $809 in 2025
The $809 reported for 2025 was more than what 85% of Acute Care (Nurse Practitioner) providers received nationally (typical 2025 total: $151).
See the full distribution for Acute Care (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $398 · 2022: $352 · 2023: $415 · 2024: $595 · 2025: $809.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,819.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,818.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endo Pharmaceuticals INC. | $297.28 | 2021-2024 | Xiaflex, Edex, Aveed |
| Abbvie INC. | $227.96 | 2022-2025 | |
| Sumitomo Pharma America, INC. | $179.06 | 2023-2025 | Gemtesa |
| Medtronic, INC. | $162.48 | 2023-2025 | Interstim |
| Astellas Pharma US INC | $148.31 | 2021 | |
| Pfizer INC. | $133.60 | 2021-2025 | |
| Boston Scientific Corporation | $124.72 | 2023-2024 | |
| Abc Home Medical Supply, INC. | $122.30 | 2024-2025 | |
| Endo USA, INC. | $113.62 | 2024-2025 | Xiaflex |
| Hollister Incorporated | $113.43 | 2022-2024 | Vapro Pocket |
| Progenics Pharmaceuticals, INC. | $96.90 | 2022-2025 | Pylarify |
| 180 Medical, INC. | $85.07 | 2023-2025 | Gentlecath, Gentlecath Glide |
| Convatec INC. | $73.47 | 2021-2022 | |
| Janssen Biotech, INC. | $70.50 | 2021-2025 | Erleada |
| Urogen Pharma, INC. | $64.18 | 2023-2024 | Jelmyto |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $62.49 | 2021-2022 | |
| Urovant Sciences INC | $49.89 | 2021-2022 | |
| Blue Earth Diagnostics | $49.60 | 2021-2022 | |
| Olympus America INC. | $49.18 | 2025 | Itind System |
| Procept Biorobotics Corporation | $48.63 | 2023-2024 | Aquabeam System, Aquabeam Robotic System |
| Vertex Pharmaceuticals Incorporated | $47.16 | 2025 | |
| Coloplast Corp | $45.79 | 2025 | |
| Verity Pharmaceuticals INC. | $42.80 | 2023-2025 | Trelstar |
| Axonics, INC. | $42.75 | 2023-2024 | Axonics |
| Ferring Pharmaceuticals INC. | $41.64 | 2025 | Adstiladrin |
| Bayer Healthcare Pharmaceuticals INC. | $20.97 | 2023 | |
| Conmed Corporation | $20.00 | 2025 | Airseal, Conmed Specimen Retrieval, Visiclear |
| Laborie Medical Technologies Corp. | $17.48 | 2025 | Optilume Bph Drug Coated Balloon Catheter |
| Ambu INC. | $16.87 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chelsey Roberts listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.